Jump to content

NSCLC with MET Clinical Trial


Recommended Posts

NSCLC with MET Clinical Trial

“You may qualify for a new clinical trial specific to your type of lung cancer. Massive Bio is working with a Pharmaceutical Sponsor to identify and determine eligibility of patients with MET-Altered Advanced Non-Small Cell Lung Cancer (NSCLC) to a novel drug in Phase 2 clinical trial. 

If you are interested in learning about this trial, please contact:
Kristin Johnston, BSN, RN, 
Chief Nursing Officer, Massive Bio, Inc. 
Phone: 267-918-3790
Email: kjohnston@massivebio.com “

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.